Company / Book Value per Share
BIOCRYST PHARMACEUTICALS INC Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.545
FY2025
5-year range
-$2.37 / -$0.545
FY2021-FY2025
Trend
+76.3%
vs FY2024
Sector context
#195 of 209
Health Care
What the data says
Among 209 Health Care companies, BIOCRYST PHARMACEUTICALS INC is in the bottom 7% for book value per share. Improved from -$2.37 to -$0.545 over the past 2 years.
Based on SEC 10-K filings.
-$0.545 in FY2025.
Improved from -$2.37 to -$0.545 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 209This company -$0.545 Sector average $215.686
▼
-100.3% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 76.3% year-over-year.
- Ranks #195 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2017.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.545 | +76.3% |
| FY2024 | -$2.303 | +2.8% |
| FY2023 | -$2.37 | -49.6% |
| FY2022 | -$1.585 | -165.3% |
| FY2021 | -$0.597 | -418.7% |
| FY2020 | -$0.115 | -134.8% |
| FY2019 | $0.331 | -30.7% |
| FY2018 | $0.477 | -58.0% |
| FY2017 | $1.135 | +5177.7% |
| FY2016 | $0.022 | -96.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026